Corvus Pharmaceuticals, Inc. (CRVS) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$43,123
Total Return
331.23%
CAGR
33.95%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +9.11% |
| Median | -1.24% |
| Best | +346.60% |
| Worst | -49.11% |
| % of Windows Positive | 48.0% |
1-Year (252 Trading Days)
| Average | +94.09% |
| Median | +71.00% |
| Best | +714.82% |
| Worst | -90.78% |
| % of Windows Positive | 69.7% |
3-Year (756 Trading Days)
| Average | +553.18% |
| Median | +268.25% |
| Best | +2783.63% |
| Worst | -39.27% |
| % of Windows Positive | 91.4% |
Risk Metrics
| Maximum Drawdown | -92.40% |
| Average Drawdown | -60.22% |
| Drawdown Duration | 780 Trading Days |
| Sortino Ratio | 1.60 |
| Calmar Ratio | 0.37 |
| CVaR (5%) | -11.10% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +50.65% (+164.30% ann.) | +$5064.93 | $0.00 | $0.00 | $0.00 |
| 2025 | +43.93% | +$4392.51 | $0.00 | $0.00 | $0.00 |
| 2024 | +203.98% | +$20397.70 | $0.00 | $0.00 | $0.00 |
| 2023 | +107.06% | +$10705.96 | $0.00 | $0.00 | $0.00 |
| 2022 | -64.73% | $6473.04 | $0.00 | $0.00 | $0.00 |
| 2021 | -32.30% | $3230.34 | $0.00 | $0.00 | $0.00 |
| 2020 | -34.56% | $3455.86 | $0.00 | $0.00 | $0.00 |
| 2019 | +48.23% | +$4822.87 | $0.00 | $0.00 | $0.00 |
| 2018 | -64.58% | $6457.53 | $0.00 | $0.00 | $0.00 |
| 2017 | -27.55% | $2755.24 | $0.00 | $0.00 | $0.00 |
| 2016 partial | +0.35% (+0.45% ann.) | +$35.09 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 23, 2016 – February 19, 2020 | -69.75% | -26.35% | $6975.44 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -55.38% | -99.99% | $5538.46 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +101.44% | +208.59% | +$10144.21 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -13.53% | -12.89% | $1353.39 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -78.27% | -80.23% | $7826.98 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +562.65% | +177.39% | +$56264.64 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +111.68% | +55.22% | +$11167.90 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.